newsfilter
← Latest News
Business Wire·

Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference

Cudetaxestat displayed direct anti-fibrotic effects on multiple biomarkers in a preclinical lung fibrosis model Non-competitive autotaxin inhibition by cudetaxestat maintained potency in the presence of elevated substrate concentrations found i